🎯 A Historic Milestone in Xenotransplantation

The field of organ transplantation has reached a pivotal moment with the successful use of a genetically modified pig liver to sustain a human patient for over a month, buying critical time for his native liver to regenerate. This case, reported in late 2025, marks the world's first auxiliary pig-to-human liver xenotransplant in a living recipient, demonstrating the potential of animal organs to bridge life-threatening gaps in human donor availability.

Xenotransplantation, the process of transplanting organs or tissues from one species to another, has long promised to alleviate the chronic shortage of donor organs. In the United States alone, over 100,000 individuals await transplants, with livers ranking as the second most needed after kidneys. More than 9,000 Americans die annually without receiving one. Globally, the crisis is even more acute, particularly in regions with limited donation infrastructure.

This breakthrough occurred at the First Affiliated Hospital of Anhui Medical University in Hefei, China, where surgeons led by Dr. Beicheng Sun performed the procedure on a 71-year-old man suffering from advanced liver disease. The patient's story underscores how pig livers could serve as a temporary lifeline, allowing time for recovery or a human donor organ.

The Global Organ Shortage Crisis

Every day, the demand for livers outstrips supply due to factors like rising rates of hepatitis, alcohol-related damage, and non-alcoholic fatty liver disease. Acute liver failure can strike suddenly, leaving patients in desperate need of support. Traditional bridges, such as dialysis-like liver dialysis machines, often fall short in fully mimicking liver functions like detoxification, protein synthesis, and bile production.

Pigs emerge as ideal donors because their organs are anatomically similar in size and physiology to humans. Advances in gene-editing technologies, such as CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats-Cas9, a precise DNA-cutting tool), enable scientists to modify pig genomes to reduce rejection risks and viral transmissions.

• Over 17 people die daily in the US waiting for a transplant.
• Liver transplants require precise timing; delays can be fatal.
• Xenotransplants could provide 'off-the-shelf' organs from pig herds, scaled for mass production.

Explore research jobs driving these innovations in academic institutions worldwide.

Understanding Xenotransplantation Basics

Xenotransplantation involves overcoming three major hurdles: hyperacute rejection (immediate immune attack), acute rejection (within days), and chronic rejection (long-term). Pigs naturally carry alpha-gal sugars and other antigens foreign to humans, triggering violent responses. They also harbor porcine endogenous retroviruses (PERVs), though editing mitigates this.

In auxiliary transplants, the pig organ supplements rather than replaces the human one, reducing risk. This approach allows monitoring and removal if issues arise, as seen in the China case.

Prior successes include pig heart transplants surviving weeks in humans and pig kidneys functioning months in brain-dead recipients. External perfusion trials, where pig livers filter blood outside the body, have also shown promise.

📋 The Landmark Case: Patient Profile and Preparation

The 71-year-old patient had hepatitis B-related cirrhosis, where scar tissue impairs liver function, and a massive hepatocellular carcinoma (HCC, primary liver cancer) in his right lobe. Chemotherapy failed to shrink the tumor, and family donors were incompatible. With his remnant liver volume at just 35% of standard (320 cm³), full removal risked death.

Surgeons resected the tumorous right lobe and implanted an entire liver from an 11-month-old cloned Diannan miniature pig. Immunosuppressants, including anti-thymocyte globulin and rituximab, were administered to curb immunity.

Photo by Sangharsh Lohakare on Unsplash

Genetic Engineering: The 10-Key Modifications

The pig underwent sophisticated 10-gene edits to humanize its liver:

• Knockouts (3): GGTA1, CMAH, β4GalNT2 – eliminating xenoantigens that provoke hyperacute rejection.
• Human transgenes (7): hCD46, hCD55, hCD59 (complement regulators preventing cell lysis); hCD39, hTBM/THBD (thrombomodulin), hEPCR (coagulation protectors); hCD47 (prevents phagocytosis by immune cells).

These changes, achieved via CRISPR, made the organ stealthier to human defenses. For deeper insights, review the study in the Journal of Hepatology.

Surgical Procedure and Early Triumphs

Post-implantation, the pig liver flushed pink, signaling viability. Bile drainage began immediately, peaking at useful levels. Liver enzymes normalized swiftly; porcine albumin appeared in blood, and coagulation factors improved.

Ultrasounds confirmed robust blood flow in hepatic artery, portal vein, and veins. No inflammation or rejection markers surfaced initially. The native left liver began regenerating, a testament to the pig organ's supportive role.

Monitoring Function: Proof of Metabolic Support

Over 38 days, the graft:

• Secreted bile, aiding fat digestion and waste removal.
• Synthesized proteins like albumin and clotting factors.
• Maintained blood sugar and detoxified substances.
• Showed histological integrity with proliferating hepatocytes.

Minimal complement deposition (C4d weak) confirmed low rejection. This outperformed prior brain-dead trials limited to 10 days.

🛡️ Challenges: Thrombotic Microangiopathy and Resolution

Around day 31, xenotransplantation-associated thrombotic microangiopathy (xTMA, microvascular clotting from endothelial damage) emerged: thrombocytopenia, hemolysis, elevated complement (sC5b-9). Adjustments to immunosuppressants helped temporarily.

By day 38, with native liver volume doubled to 610 cm³, surgeons explanted the pig liver. Eculizumab (complement inhibitor) and plasma exchange resolved xTMA. The patient lived 171 days total, dying from unrelated GI bleeding.

Compare to earlier six-gene pig liver trial in a brain-dead patient.

Photo by Sangharsh Lohakare on Unsplash

Future Implications: Revolutionizing Liver Care

This proves pig livers can bridge acute/chronic failures or post-resection scenarios. Dr. Heiner Wedemeyer noted it 'opens completely new views' for hepatologists. Scalable pig farms could end waitlists.

Related advances: A US man thrives six months post-pig kidney. FDA trials for pig livers as bridges are underway.

Ethical considerations include animal welfare (cloned pigs bred humanely) and equitable access. Regulations evolve, with NIH monitoring PERVs.

Research Opportunities in Xenotransplantation

Academia fuels this field. Institutions seek experts in gene editing, immunology, and surgery. Pursue clinical research jobs or postdoc positions advancing CRISPR applications.

Share experiences with professors pioneering this at Rate My Professor. Discover higher ed jobs in biomedicine.

In summary, this pig liver success heralds abundant organs. Explore university jobs or career advice to contribute. Visit higher-ed-jobs for openings, and rate your professors in transplant research.